IHL 0.00% 4.1¢ incannex healthcare limited

Ann: IHL initiates psilocybin clinical trial for anxiety disorder, page-21

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,861 Posts.
    lightbulb Created with Sketch. 509
    Assuming its due to previous trials being made using Psilocybin, so they know it has a good safety profile in human trials to date?
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.